Congress Reauthorizes the Animal Drug User Fee Act
WASHINGTON — The Animal Drug User Fee Act (ADUFA) passed the House of Representatives last night with a vote of 390-12. With the passage of ADUFA last month in the Senate, the legislation, which authorizes the Food and Drug Administration (FDA) to collect fees for certain animal drug applications, now heads to the White House for the President's signature.
Reauthorization of ADUFA is one of the National Cattlemen's Beef Association's (NCBA) top policy priorities. NCBA President Scott George, a dairy and beef producer from Cody, Wyo., said the passage of ADUFA is important because new animal health technologies allow cattle producers and veterinarians to prevent, control and treat diseases to maintain a healthy herd.
“Raising healthy cattle is of utmost importance to cattlemen and women, and it is important for producers and the veterinarians they work with to have the ability to best manage herd health and produce safe, nutritious beef,” said George. "The reauthorization of ADUFA will provide resources for the FDA to conduct timely and thorough reviews of new animal drugs for safety and effectiveness."
George added that with a "clean" bill free of amendments, the fees paid by animal health companies to fund FDA reviews and evaluations will be utilized to support and facilitate the new animal drug approval process.
"Cattle producers know that keeping our animals healthy is critical to the viability of our operations and our industry," said George. "We sincerely thank the Senate and House leadership for working together to pass this legislation and for realizing the importance of passing a clean bill without unnecessary language or amendments."